¿°Áõ¼º ÀåÁúȯ ȯÀÚ¿¡¼ COVID-19 ´ëó¹æ¾È
How to Cope with COVID-19 in Patients with Inflammatory Bowel Disease
´ëÇѼÒȱâÇÐȸÁö 2021³â 77±Ç 4È£ p.160 ~ p.163
ÀÌÀ¯Áø(Lee Yoo-Jin) - Keimyung University School of Medicine Department of Internal Medicine
Abstract
Patients with inflammatory bowel disease (IBD) are generally considered to be more vulnerable to coronavirus disease 2019 (COVID-19). In addition, there are many concerns about the risk of severe COVID-19 infection in patients with IBD. Because the uncertainty of COVID-19 can cause confusions for patients with chronic diseases, physicians should be able to provide adequate advice for optimal treatment for patients with IBD. As the COVID-19 pandemic continues, current knowledge of COVID-19 is changing based on numerous empirical guidance and clinical data being updated daily. Based on the latest evidence, we will discuss the appropriate strategy and management of patients with IBD in the era of COVID-19.
Å°¿öµå
COVID-19, Pandemics, Inflammatory bowel diseases
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
À¯È¿¼º°á°ú(Recomendation)
Patients with inflammatory bowel disease (IBD) are generally considered to be more vulnerable to coronavirus disease 2019 (COVID-19). As the COVID-19 pandemic continues, current knowledge of COVID-19 is changing based on numerous empirical guidance and clinical data being updated daily.